Akebia Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Akebia Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Akebia Therapeutics Inc.
Rating: 1.511111125
Author: Trendlyne DVM scores

Momentum Trap

about

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company include...

3.14 0.01 (0.32%)

149.21% Gain from 52W Low

2.4M

XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Low Financial Strength

27.8 / 100

Expensive Valuation

11.3 / 100

Technically Neutral

54.0 / 100

Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 136%

5 analysts

Akebia Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Akebia Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company include...

149.21% Gain from 52W Low

SWOT Analysis

Akebia Therapeutics Inc. Live Price Chart